Hemobilia: another complication associated with anti-thrombotic therapy
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : Yukiko Hiramatsu Tomohiro Watanabe Masahiro Shiokawa Akira Kurita Minoru Matsuura Norimitsu Uza Yuzo Kodama Tsutomu Chiba
- چاپ و سال / کشور: 2011
Description
It is generally accepted that anti-thrombotic therapy increases the risk of gastrointestinal bleeding, and concurrent therapy with a proton-pump inhibitor is the standard treatment for patients receiving aspirin. Therefore, much attention has been paid to the prevention of gastrointestinal bleeding in such patients; however, it should be noted that patients on anti-thrombotic therapy always carry a risk of hemorrhage from any organ, including the gastrointestinal tract. Here, we present a case with formation of a common bile duct stone caused by hemobilia associated with anti-thrombotic therapy. This case suggests that we need to be aware of the possibility of intrabiliary hemorrhage as well as gastrointestinal bleeding in patients receiving anti-thrombotic therapy. Patients with such complications show a variety of symptoms including liver abscess, cholangitis, pancreatitis, and duodenal bleeding
Clin J Gastroenterol (2011) 4:49–51 Received: 8 November 2010 / Accepted: 29 November 2010 / Published online: 18 December 2010 Springer 2010
